Journal of the Korean Medical Association

| Opinion | February 10, 2023

How do we trade off benefits and harms of anticancer drugs for advanced cancer patients?

Do Yeun Kim

J Korean Med Assoc. 2023;66(2):86-90.

Background: The overall survival rate of advanced cancer patients has improved thanks to the development of modern medical treatments, particularly new and innovative chemotherapeutic agents such as targeted therapies and...

Management of the adverse effects of anticancer chemotherapy | Focused Issue of This Month | February 10, 2023

Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare

Ji Hyung Hong

J Korean Med Assoc. 2023;66(2):92-104.

Background: Despite the increased incidence of cancer, more effective cancer drugs are being developed and cancer patient survival expectancy has been prolonged. Here, we discuss the contribution of primary healthcare...

Management of the adverse effects of anticancer chemotherapy | Focused Issue of This Month | February 10, 2023

Management of the adverse effects of targeted therapy for cancer

Hyewon Ryu

J Korean Med Assoc. 2023;66(2):105-111.

Background: Advances in genomics and molecular biology over the past 20 years have resulted in numerous approved molecular targeted cancer therapies. The two main approaches for targeted cancer therapy are...

Management of the adverse effects of anticancer chemotherapy | Focused Issue of This Month | February 10, 2023

Management of the adverse effects of cancer immunotherapy with a focus on the gastrointestinal and hepatic systems

Jaekyung Cheon

J Korean Med Assoc. 2023;66(2):112-115.

Background: Immunotherapy has become established as a new cancer treatment that enhances patients’ immune systems’ ability to fight cancer. Immune checkpoint inhibitors (ICI) have demonstrated remarkable benefits in the treatment...

Management of the adverse effects of anticancer chemotherapy | Focused Issue of This Month | February 10, 2023

Management of the adverse effects of cancer immunotherapy with a focus on the respiratory and nervous systems

Song Ee Park

J Korean Med Assoc. 2023;66(2):116-122.

Background: The incidence of adverse toxic reactions to immunotherapy using immune checkpoint inhibitors is 2-10% in the respiratory system and 3.9% to 12% in the neurologic system. The severity of...

| Continuing Education Column | February 10, 2023

Diagnosis and treatment of sodium hypochlorite poisoning with ingestion of household bleaching agents

Jeong Mi Moon, Byeong Jo Chun, Yong Soo Cho

J Korean Med Assoc. 2023;66(2):123-129.

Background: Sodium hypochlorite is commonly used as a household bleaching agent (for example, the Clorox brand). Sodium hypochlorite poisoning with ingestion of a bleaching agent is often observed in clinical...

| Health Statistics of Korea | February 10, 2023

Cause-of-death statistics in 2020 in the Republic of Korea

Vital Statistics Division, Statistics Korea , Hyongjoon Noh, Juhee Seo, et al.

J Korean Med Assoc. 2023;66(2):132-142.

Background: This study analyzed the causes of death in the Korean population in 2020. Methods: Cause-of-death data for 2020 from Statistics Korea were examined based on the Korean Standard Classification of...

| Special Contribution | February 10, 2023

Proposal to establish a hospital dedicated for surgical essential medicines: a pilot project to strengthen the essential medical service in Korea

Phils Kim

J Korean Med Assoc. 2023;66(2):143-151.

Background: In December 2022, the Ministry of Health and Welfare of the Korean government announced the “action plan for essential medicine (EM),” featuring that the regional emergency centers in tertiary...

How do we trade off benefits and harms of anticancer drugs for advanced cancer patients? Do Yeun Kim J Korean Med Assoc. 2023;66(2):86-90. Opinion February 10, 2023 Full text PubReader ePub PDF	Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare Ji Hyung Hong J Korean Med Assoc. 2023;66(2):92-104. Focused Issue of This Month February 10, 2023 Management of the adverse effects of anticancer chemotherapy Full text PubReader ePub PDF
Management of the adverse effects of targeted therapy for cancer Hyewon Ryu J Korean Med Assoc. 2023;66(2):105-111. Focused Issue of This Month February 10, 2023 Management of the adverse effects of anticancer chemotherapy Full text PubReader ePub PDF	Management of the adverse effects of cancer immunotherapy with a focus on the gastrointestinal and hepatic systems Jaekyung Cheon J Korean Med Assoc. 2023;66(2):112-115. Focused Issue of This Month February 10, 2023 Management of the adverse effects of anticancer chemotherapy Full text PubReader ePub PDF
Management of the adverse effects of cancer immunotherapy with a focus on the respiratory and nervous systems Song Ee Park J Korean Med Assoc. 2023;66(2):116-122. Focused Issue of This Month February 10, 2023 Management of the adverse effects of anticancer chemotherapy Full text PubReader ePub PDF	Diagnosis and treatment of sodium hypochlorite poisoning with ingestion of household bleaching agents Jeong Mi Moon, Byeong Jo Chun, Yong Soo Cho J Korean Med Assoc. 2023;66(2):123-129. Continuing Education Column February 10, 2023 Full text PubReader ePub PDF Self-study
Cause-of-death statistics in 2020 in the Republic of Korea Vital Statistics Division, Statistics Korea , Hyongjoon Noh, Juhee Seo, et al. J Korean Med Assoc. 2023;66(2):132-142. Health Statistics of Korea February 10, 2023 Full text PubReader ePub PDF Supplementary Material	Proposal to establish a hospital dedicated for surgical essential medicines: a pilot project to strengthen the essential medical service in Korea Phils Kim J Korean Med Assoc. 2023;66(2):143-151. Special Contribution February 10, 2023 Full text PubReader ePub PDF Supplementary Material